| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.19 | 0.0007 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.21 | 0.006 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.11 | 0.08 |